Bezinga Conference: Breaking the stigma of the use of psychedelics in medicines and therapies

Panel
Written By Reid Robison, MD MBA

I had a great opportunity to be a panelist for this event, along with Dr. Joseph Tucker, MD and CEO of MagicMed Industries, and Timothy Ko, CEO of Entheon Biomedical. We review the stigma around the use of psychedelics and how it relates to the future of mental health.

Reid Robison, MD MBA
Previous

Center for Change: Innovative treatment for eating disorders
Next

The Urban Monk Academy: Emotional trauma course